Genomic testing, targeted and immunotherapy for lung cancer: past, present, and future
Robin Cornelissen, Rotterdam / Netherlands
1. To get insight in the rapidly evolving field of genomic testing in lung cancer.
2. To get an overview of numerous forms of targeted therapy that are currently available or in development.
3. To understand the mechanisms of resistance on targeted therapy and the different subsequent treatments.